Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

The incidence of Kawasaki disease after vaccination within the UK pre-school National Immunisation Programme: an observational THIN database study.

Hall GC, Tulloh RM, Tulloh LE.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1331-1336. doi: 10.1002/pds.4108.

PMID:
27651105
2.

Sildenafil, pulmonary hypertension and bronchopulmonary dysplasia.

Herbert S, Tulloh R.

Early Hum Dev. 2016 Nov;102:21-24. doi: 10.1016/j.earlhumdev.2016.09.009.

PMID:
27665322
3.

Guanylate cyclase stimulators for pulmonary hypertension.

Wardle AJ, Seager MJ, Wardle R, Tulloh RM, Gibbs JS.

Cochrane Database Syst Rev. 2016 Aug 2;(8):CD011205. doi: 10.1002/14651858.CD011205.pub2. Review.

PMID:
27482837
4.

Kawasaki disease incidence in children and adolescents: an observational study in primary care.

Hall GC, Tulloh LE, Tulloh RM.

Br J Gen Pract. 2016 Apr;66(645):e271-6. doi: 10.3399/bjgp16X684325.

PMID:
26906631
5.

Cellular and molecular basis of RV hypertrophy in congenital heart disease.

Iacobazzi D, Suleiman MS, Ghorbel M, George SJ, Caputo M, Tulloh RM.

Heart. 2016 Jan;102(1):12-7. doi: 10.1136/heartjnl-2015-308348. Review.

6.

Cardiovascular status after Kawasaki disease in the UK.

Shah V, Christov G, Mukasa T, Brogan KS, Wade A, Eleftheriou D, Levin M, Tulloh RM, Almeida B, Dillon MJ, Marek J, Klein N, Brogan PA.

Heart. 2015 Oct;101(20):1646-55. doi: 10.1136/heartjnl-2015-307734.

7.

Anomalous Left Coronary From the Pulmonary Artery Presenting as Ventricular Fibrillation After Persistent Ductus Arteriosus Ligation.

Fudulu DP, Tulloh RM, Wolf AR, Parry AJ, Stoica SC.

Ann Thorac Surg. 2015 Jul;100(1):e9-e10. doi: 10.1016/j.athoracsur.2015.04.015.

PMID:
26140805
8.

Lung function in pulmonary hypertension.

Low AT, Medford AR, Millar AB, Tulloh RM.

Respir Med. 2015 Oct;109(10):1244-9. doi: 10.1016/j.rmed.2015.05.022. Review.

PMID:
26033642
9.

Sildenafil in bronchopulmonary dysplasia: safe to use?

Wardle AJ, Connolly GM, Stonier T, Tulloh R.

Arch Dis Child Fetal Neonatal Ed. 2015 Jul;100(4):F369. doi: 10.1136/archdischild-2015-308164. No abstract available.

PMID:
25716676
10.

Pulmonary arterial hypertension exacerbated by ruxolitinib.

Low AT, Howard L, Harrison C, Tulloh RM.

Haematologica. 2015 Jun;100(6):e244-5. doi: 10.3324/haematol.2014.120816. No abstract available.

11.

Fifteen-minute consultation: rheumatic fever.

Markham R, Tulloh R.

Arch Dis Child Educ Pract Ed. 2015 Aug;100(4):176-9. doi: 10.1136/archdischild-2014-306545. Review.

PMID:
25653243
12.

Authors' response to 'aspirin dose for treatment of Kawasaki disease'.

Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein N, Brogan P.

Arch Dis Child. 2015 Mar;100(3):300-1. doi: 10.1136/archdischild-2014-307798. No abstract available.

PMID:
25425602
13.

Kawasaki disease.

Harnden A, Tulloh R, Burgner D.

BMJ. 2014 Sep 17;349:g5336. doi: 10.1136/bmj.g5336. Review. No abstract available.

PMID:
25230954
14.

Does the persistence of pulsatile antegrade pulmonary blood flow following bidirectional Glenn procedure affect long term outcome?

Chen Q, Tulloh R, Caputo M, Stoica S, Kia M, Parry AJ.

Eur J Cardiothorac Surg. 2015 Jan;47(1):154-8; discussion 158. doi: 10.1093/ejcts/ezu170.

PMID:
24787474
15.

Prevention and prophylaxis of respiratory syncytial virus in pediatric cardiology: a UK perspective.

Tulloh RM, Bury S.

Future Cardiol. 2014 Mar;10(2):235-42. doi: 10.2217/fca.14.4. Review.

PMID:
24762251
16.

Comparison of the effect of inhaled anaesthetic with intravenous anaesthetic on pulmonary vascular resistance measurement during cardiac catheterisation.

Giesen LA, White M, Tulloh RM.

Cardiol Young. 2015 Feb;25(2):368-72. doi: 10.1017/S1047951114000195.

PMID:
24548796
17.

Adaptations of aortic and pulmonary artery flow parameters measured by phase-contrast magnetic resonance angiography during supine aerobic exercise.

Pieles GE, Szantho G, Rodrigues JC, Lawton CB, Stuart AG, Bucciarelli-Ducci C, Turner MS, Williams CA, Tulloh RM, Hamilton MC.

Eur J Appl Physiol. 2014 May;114(5):1013-23. doi: 10.1007/s00421-014-2833-x.

PMID:
24504653
18.

Management of Kawasaki disease.

Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA.

Arch Dis Child. 2014 Jan;99(1):74-83. doi: 10.1136/archdischild-2012-302841. Review.

19.

Patent ductus arteriosus: an analysis of management.

Wardle AJ, Osman A, Tulloh R, Luyt K.

Cardiol Young. 2014 Oct;24(5):941-3. doi: 10.1017/S1047951113001583.

PMID:
24153161
20.

High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometry.

Westbury SK, Lee K, Reilly-Stitt C, Tulloh R, Mumford AD.

Thromb Res. 2013 Aug;132(2):e145-51. doi: 10.1016/j.thromres.2013.07.006.

PMID:
23906940
Items per page

Supplemental Content

Loading ...
Support Center